JTM

official impact factor 3.51
Search for
Advanced search
Journal of Translational Medicine
Tools
Share this article
Open Access

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

Tetsuhiro Tsuruma*, Yuji Iwayama, Tosei Ohmura, Tadashi Katsuramaki, Fumitake Hata, Tomohisa Furuhata, Koji Yamaguchi, Yasutoshi Kimura, Toshihiko Torigoe, Nobuhiko Toyota, Atsuhito Yagihashi, Yoshihiko Hirohashi, Hiroko Asanuma, Kumiko Shimozawa, Minoru Okazaki, Yasuhiro Mizushima, Naohiro Nomura, Noriyuki Sato and Koichi Hirata

Journal of Translational Medicine 2008, 6:24 doi:10.1186/1479-5876-6-24

Accesses  

  • Last 30 days: 66 accesses
  • Last 365 days: 659 accesses
  • All time: 3333 accesses

Cited by

BioMed Central: 1 citation

Research   Open Access

Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients

Jun-ichi Kobayashi, Toshihiko Torigoe, Yoshihiko Hirohashi, Satomi Idenoue, Akihiro Miyazaki, Akira Yamaguchi, Hiroyoshi Hiratsuka, Noriyuki Sato Journal of Translational Medicine 2009, 7:1 (6 January 2009)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations